Our findings indicate that CREB3L2 can enhance lipogenesis in HCC cells by up-regulating the key enzyme involved in fatty acid synthesis, which energizes the malignant proliferation and metastasis of tumor cells. Here, CREB3L2 is linked to hepatocellular carcinoma.